ContributorsPublishersAdvertisers

The Benefit of CAR T-Cell Therapy in Indolent Lymphoma

cancernetwork.com
 2021-10-12

Cover picture for the articleCaron A. Jacobson, MD, MMSC, highlights data supporting the use of CAR T-cell therapy in patients with indolent lymphoma. Those with B-cell histology have derived positive clinical benefit from treatment with CD19-targeted chimeric antigen receptor (CAR) T-cell therapy, with those with indolent B-cell non-Hodgkin lymphoma achieving a high rate of durable...

www.cancernetwork.com

Comments / 0

Comments / 0